Skip to main content
. 2018 Apr 23;9(7):612–617. doi: 10.1021/acsmedchemlett.8b00014

Table 1. Cancer Cell Line Response to Compound 1 in 7-Day Proliferation Assay (Supporting Information).

cell line histology IC50 (μM) max inhibition (%)
HCC1937 breast 0.030 83
T-42D breast 0.003 84.0
UACC-812 breast >2.5 21.0
MX-1 cells breast >2.5 36.9
NUGC-3 gastric 0.017 92
KE-97 gastric 0.024 95.7
MV4–11 hematological 0.016 93
Daudi hematological 0.017 99.3
Karpas-422 hematological 0.085 99.9
HEL 92.1.7 hematological 0.003 91.2
ARH-77 hematological 0.010 97.2
REC-1 hematological 0.022 99.7
IM-9 hematological 0.046 93
KMS-12-BM hematological 0.006 99
RPMI-8226 hematological 0.009 88.5
OPM-2 hematological >2.5 22.5
NCI-H2171 lung 0 010 97.7
H-2122 lung 0.027 90
NCI-H1930 lung >2.5 49.6
NCI-H1651 lung >2.5 32
A375 skin 0.037 91.1
A2058 skin 0.013 96
GAK skin 0.016 99.9
Colo829 skin 0.013 51
OVCAR-3 ovarian 0.032 95